PhRMA

JANUARY 25, 2023

Earlier this month, the American Cancer Society (ACS) released its annual report, Cancer Statistics 2023, finding the overall cancer mortality rate has declined 33% since peaking in 1991, leading to an estimated 3.8 million averted cancer deaths over this period. The report notes the continued decline in death rates since 1991, including a 1.5% decrease between 2019 and 2020 alone, increasingly reflects advances in prevention and treatment—including new medicines which have improved survival acr

Documentation 254

Documentation 254

Pharmacy Is Right For Me

JANUARY 25, 2023

There are so many different types of careers within the field of pharmacy—from research and drug development to pharmacy informatics! To highlight some of the more unique career settings in the industry, we’re introducing a new page on our website— Novel Pharmacy Practice Settings —where you can explore these unique career pathways. In addition to learning more about unique pathways on our new webpage, we’ll also be featuring pharmacists who work in these unique settings on our blog.

Community Pharmacies 130

Community Pharmacies Insurance Patient Care 130

Drug Topics

JANUARY 25, 2023

Mallya can provide convenience for insulin pen users; however, it has yet to be released in the United States.

FDA 187

FDA 187

Fierce Pharma

JANUARY 25, 2023

Merck's Keytruda dealt another blow in prostate cancer but readies new challenge to AZ's Imfinzi aliu Wed, 01/25/2023 - 10:17

135

135

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

JANUARY 25, 2023

COVID-19 caused surge in heart disease deaths in first year of pandemic: report fdiamond Wed, 01/25/2023 - 08:44

139

139

pharmaphorum

JANUARY 25, 2023

Digital therapeutics company Woebot Health has announced enrolment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational therapeutic for postpartum depression (PPD), granted Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2021. The double-blind, randomised, controlled trial will evaluate WB001, a Software as a Medical Device (SaMD) based Cognitive Behavioural Therapy (CBT) program for the treatment of mil

Dosage 96

Dosage FDA 96

Fierce Healthcare

JANUARY 25, 2023

Payer startup Angle Health scores $58M to scale operations, expand to new markets agliadkovskaya Wed, 01/25/2023 - 09:42

124

124

STAT

JANUARY 25, 2023

Two new studies published Wednesday report good news about the updated Covid-19 vaccine, with one suggesting it is more effective than the previous monovalent vaccine and the other showing that even though it targeted an earlier strain of the SARS-CoV-2 virus, its protection is holding up against current variants. The findings suggest the updated vaccine, which targets both the original SARS-2 virus and the Omicron subvariants BA.4 and BA.5, is performing better than some critics of the decision

Vaccines 100

Vaccines 100

Drug Store News

JANUARY 25, 2023

This year’s winners pay homage to legacy brands that have been mainstays in the drug store channel’s natural section as well as new brands that have created a name for themselves.

98

98

Med Ed 101

JANUARY 25, 2023

In this article, we lay out our top 5 all-time hypertension clinical trials. If you remember previously, we covered the top 5 landmark clinical trials in hyperlipidemia. It was a tough call with many options, but here’s our list of hypertension clinical trials. Feel free to comment below if you feel we missed one! DASH […] The post Top 5 All-Time Hypertension Clinical Trials appeared first on Med Ed 101.

98

98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Store News

JANUARY 25, 2023

The agency told its staff that it expects to make several changes internally, with some offices merging their responsibilities and new offices being created, according to a report.

98

98

pharmaphorum

JANUARY 25, 2023

Life sciences marketing has rapidly evolved to mirror that of consumer retail. There are now more ways than ever to interact with customers, from traditional channels like email and phone calls to more modern approaches like social media and texting, and new ways to engage customers are emerging every year. So, how can companies maximise the effectiveness of customer engagement strategies when there are so many digital and physical mediums of interaction to choose from?

Communication 96

Communication 96

Hospital Pharmacy Europe

JANUARY 25, 2023

The Joint Committee on Vaccination and Immunisation (JCVI) has advised offering Covid booster vaccinations in spring and autumn 2023 for patients deemed to be at high risk. Interim advice to the UK Government has recommended that planning begin for a 2023 autumn booster programme for those at higher risk of severe Covid-19 because of age or clinical risk factors.

Vaccines 98

Vaccines Immunization Hospitals 98

The Checkup by Singlecare

JANUARY 25, 2023

If you’ve decided it’s time to lose the extra weight you’ve been carrying around, here’s some motivation: You can experience a number of health benefits from just a modest amount of weight loss. Losing just 5% to 10% of your total body weight can help you sleep better at night, maintain better control over your blood sugar levels, and lower your risk of cardiovascular disease, according to the Centers for Disease Control and Prevention (CDC).

Mayo Clinic 98

Mayo Clinic Insurance 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Drug Store News

JANUARY 25, 2023

Drug Store News spoke to Howard Murad, a board-certified dermatologist, pharmacist and founder of Murad Skincare, about the brand’s new Eczema Control line and how it caters to all consumers.

98

98

STAT

JANUARY 25, 2023

After a year defined by record inflation and double-digit health care premium increases, I hope that a few years down the road we can eventually look back at 2023 as the year that ignited change in U.S. health care and led to a new system that future generations are proud of. I’ll be doing everything I can to make that happen.

Insurance 98

Insurance 98

Hospital Pharmacy Europe

JANUARY 25, 2023

Glyphosate is commonly used as a herbicide and a study in farmers has observed positive associations with biomarkers of oxidative DNA damage Regular use by farmers of the herbicide glyphosate is linked with higher levels of urinary biomarkers of oxidative stress and which represents a key characteristic of carcinogens, according to a study by US researchers.

Hospitals 98

Hospitals 98

STAT

JANUARY 25, 2023

The Food and Drug Administration aims to conduct priority reviews of at least two product applications for granting over-the-counter status to intranasal formulations of naloxone, an overdose-reversal drug. Naloxone prevents overdose deaths by binding to opioid receptors in the brain and blocking entry to competing opioids, or pushing them aside. The drug is sold in three versions: vials of injectable naloxone, auto-injectors (similar to EPIPENs) and as an intranasal spray.

96

96

European Pharmaceutical Review

JANUARY 25, 2023

Regulators, medicine manufacturers and suppliers have been urged by the World Health Organization (WHO) to take action against contaminated medicines in the supply chain. This is based on recent incidents of over-the-counter cough syrups with high levels of diethylene glycol (DEG) and ethylene glycol (EG). The lingering menace of diethylene glycol / ethylene glycol adulteration Over the past four months, cases from at least seven countries have been associated with over 300 fatalities in three o

95

95

STAT

JANUARY 25, 2023

Vir Biotechnology CEO George Scangos said on Wednesday he will retire, ending an itinerant, nearly 40-year-career as one of biotech’s most recognizable executives. Scangos, 74, will be succeeded in April by Marianne De Backer , a longtime pharma executive who currently heads pharmaceutical strategy at Bayer. She will inherit a company that rose to prominence during the pandemic by developing the antibody drug sotrovimab and is trying to repeat the success with a series of candidates for C

96

96

Fierce Healthcare

JANUARY 25, 2023

Health system hospitals, physicians deliver 'marginally' better care at higher cost than independent peers: study dmuoio Wed, 01/25/2023 - 13:52

Hospitals 104

Hospitals 104

STAT

JANUARY 25, 2023

In a rare move, the Better Business Bureau National Programs settled a dispute between two big drug companies over a prescription drug ad, suggesting the nonprofit may take a larger role in resolving complaints that might normally be handled by the U.S. Food and Drug Administration. The dispute began when Eli Lilly challenged some of the information in an ad that Novartis had run for its Kisqali breast cancer treatment.

FDA 95

FDA 95

Fierce Healthcare

JANUARY 25, 2023

State-by-state licensure is anachronistic in the age of teletherapy, providers say aburky Wed, 01/25/2023 - 14:52

113

113

STAT

JANUARY 25, 2023

Almost a year ago, three top investors at Lux Capital and Obvious Ventures announced they were leaving the firms, teasing on Twitter that they were starting “something new.” That something is a new venture capital firm, which launched Wednesday with $350 million for its first fund.

93

93

Fierce Pharma

JANUARY 25, 2023

After years of back-and-forth, Gilead's CAR-T Yescarta sways England's cost watchdog NICE fkansteiner Wed, 01/25/2023 - 18:51

107

107

STAT

JANUARY 25, 2023

Belgian antitrust regulators fined Novartis nearly $2.8 million for making misleading statements about a treatment for a serious eye disease, the latest instance in which the company was cited by a government for anticompetitive practices in connection with the medication. The fine is only the latest act in a long-running drama over Lucentis, which is used to treat age-related macular degeneration, a common disease among older adults that can lead to blindness.

92

92

Drug Store News

JANUARY 25, 2023

The virtual care program is now available nationwide to Aetna commercial members enrolled in eligible fully insured and self-insured health plans.

Insurance 98

Insurance 98

STAT

JANUARY 25, 2023

WASHINGTON — Congress just boosted the FDA’s authority over the post-market clinical trials that are a condition of speedy drug approvals, and industry lobbyists are anxious to know how the agency plans to wield that new power, which includes criminal prosecution. The Food and Drug Administration’s accelerated approval program is popular with patients who want treatments for life-threatening conditions as soon as possible.

FDA 90

FDA 90

Drug Store News

JANUARY 25, 2023

Kroger Health has established a clinical trial site network to increase reach and access to research studies.

111

111

STAT

JANUARY 25, 2023

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite the cloudy skies looming over the Pharmalot campus. After all, the birds are still chirping and a tolerable breeze is wafting by. Moreover, this marks the middle of the week, which means we have managed to survive this far. And this calls for celebration, yes? So please join us as we hoist another cup of delicious stimulation.

87

87

Fierce Healthcare

JANUARY 25, 2023

Medicare Advantage plans brace for final controversial risk adjustment rule by Feb.

125

125

Drug Store News

JANUARY 25, 2023

The new flavor-packed pints — Bossin’ Cream Pie and Raspberry Cheesecake — contain decadent layers of chocolate ganache, the company said.

97

97

Fierce Healthcare

JANUARY 25, 2023

Wave of leading medical schools pull out of U.S.

Medical Schools 138

Medical Schools 138

Drug Store News

JANUARY 25, 2023

H-E-B officially opened its store in Cibolo, Texas, the first location for the retailer in the community northeast of San Antonio.

98

98